The anti-beta 2 glycoprotein I (β2GPI) antibody is well-known as the main anti-phospholipid antibodies (aPL) that characterize the autoimmune disease antiphospholipid syndrome (APS). This evidence concerns the gene APOH and autoimmune disease.